Updated May 2 at 2:02pm
Biotechnology
53 results total, viewing 41 - 50
Industry professionals in the STEM (science, technology, engineering and math) fields are needed as volunteer chaperones for “STEM in the Middle 2015,” according to Tech Collective, Rhode Island’s information technology and bioscience industry organization. more
The Defense Threat Reduction Agency is investing $5.2 million for the development of a new type of vaccine against Q fever, and a local company is involved in the effort. more
PROVIDENCE — The elements of a mixed-use project that could cover five acres of the former Interstate 195 land were revealed last week in a public overview by the development team. The project, a joint effort of CV Properties LLC of … more
Last week Nabsys Inc. shut its doors, costing approximately 40 people their jobs and investors about $50 million. That's the nature of the beast in the high-risk biotech field. But by some of the reaction to the company's failure, it is … more
PROVIDENCE – Nabsys Inc., a life sciences company that was trying to bring its genome-mapping products to market, has closed, throwing approximately 40 people out of work. An employee who declined to give her name answered the phone at … more
With equally strong interests in biology and visual arts, Rebecca Wojciechowicz enjoyed a quintessentially Brown undergraduate experience, parlaying the open curriculum into a dual concentration that she completed in 2014. But then she stayed to earn a master’s degree in biotechnology. more
After sitting out for most of the biotech acquisition frenzy of 2015, Amgen Inc. is ready to do a deal. more
A smart wristband invented by University of Rhode Island students to monitor Parkinson’s disease was a finalist in a recent international design competition. more
Beltone New England, a national leader in hearing care, is hosting a “Hear for Children” campaign throughout the rest of September to raise funds for pediatric audiology at Hasbro Children’s Hospital. more
For all the fuss over tax inversions and the Obama administration’s efforts to prevent them, shares of companies that were able to plow their inversion deals through to the finish line and lock in all those (some would call them nefarious) benefits have to be soaring, right? Not so for Medtronic. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 Next »